Medical Devices

June 16, 2017

Buy ($175)

Companies covered: Becton, Dickinson and Company (NYSE:BDX), C.R. Bard, Inc. (NYSE:BCR), Medtronic, Inc. (NYSE:MDT), Abbott Laboratories (NYSE:ABT), Baxter International Inc. (NYSE:BAX), Edwards Lifesciences Corporation (NYSE:EW), Boston Scientific Corporation (NYSE:BSX), Cardinal Health, Inc. (NYSE:CAH), Varian Medical Systems, Inc. (NYSE:VAR), Patheon NV (NYSE:PTHN), Catalent, Inc. (NYSE:CTLT), Hill-Rom Holdings Inc (NYSE:HRC), STERIS Corporation (NYSE:STE), Invacare Corporation (NYSE:IVC), Integer Holdings Corp (NYSE:GB), Halyard Health, Inc. (NYSE:HYH), Thermo Fisher Scientific Inc (NYSE:TMO), Danaher Corporation (NYSE:DHR), Waters Corporation (NYSE:WAT), PerkinElmer, Inc. (NYSE:PKI), Agilent Technologies, Inc. (NYSE:A), Biotricity (OTCMKTS:BTCY), IsoRay, Inc. (NYSEAMERICAN:ISR), Tactile Systems Technology, Inc. (NASDAQ:TCMD), Second Sight Medical Products, Inc. (NASDAQ:EYES)